Providing Unbiased & Inclusive Information from the Entire Industry
Federal Appeals Court Rules Against DEA In Psilocybin Rescheduling Lawsuit Brought By Doctor Who Wants To Give Psychedelic To Cancer Patients – Marijuana Moment
A federal appeals court has ruled against the Drug Enforcement Administration (DEA) in a lawsuit over a Washington State doctorÕs petition to reschedule psilocybin. The court said DEA failed to...
Read More
How Magic Mushrooms Affect Our 5 Senses According to Research
While magic mushrooms donÕt alter your senses directly, they modify how your brain processes external stimuli, heightening sensations or producing d
Read More
New Research Exploring Psychedelics as a Treatment for Anxiety in Cancer Patients | High Times
Researchers across the country are studying psychedelics such as psilocybin and MDMA as potential treatments for mental health conditions commonly experienced by cancer patients.
Read More
Growing Up Menken: Singer-Songwriter Anna Rose Talks Country, Cannabis and Psilocybin
On the heels of a new album, 'Last Girl of the Rodeo,' she also shares which of her dad's songs she'd smoke to, and reveals they're working on a project...
Read More
Cybin Becomes Foremost Leader In DMT Research With Closing Of Small Pharma Acquisition – The Dales Report
Cybin Inc. has officially closed the most transformative acquisition in the psychedelic sector this year with the rollup of Small Pharma Inc
Read More
The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience
The emerging neuroscientific frontier of brain fingerprinting has recently established that human functional connectomes (FCs) exhibit fingerprint-like idiosyncratic features, which map onto heterogeneously distributed behavioural traits. Here, we harness brain-fingerprinting...
Read More
Eureka Becomes The 6th City In California To Decriminalize Psychedelics | Psychedelic Spotlight
Eureka, California Becomes The 5th City In California To Decriminalize Psychedelics
Read More
Study Finds Psilocybin Use Associated With Mental Health Benefits | High Times
A new study of psilocybin taken in a non-clinical setting has determined that participants saw mental health improvements including reduced anxiety and depression.
Read More
Why Do Some People Experience Anxiety During a Mushroom Trip? | Psychedelic Spotlight
Anxiety is one of the most common mental disorders, affecting 4.05% of the global population. While many psychedelic users turn to these substances ho
Read More
Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States
In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.
Read More
Are Psychedelic Studies Making an Academic Comeback? | Observer
The field of therapeutic psychedelics research is attracting multi-million dollar investments from private donors.
Read More
Roland Griffiths, Honorable Researcher Who Catalyzed the Psychedelic Renaissance, Dies at 77 | Psychedelic Spotlight
Roland Griffiths' trailblazing work in the psychedelics field has left an indelible imprint, inspiring a brand new generation of researchers to furthe
Read More
Sound Waves Treatment to Blast Liver Tumors Gains FDA Approval
The FDA has approved a technique using sound waves against liver tumors, according to the University of Michigan, where it was developed.
Read More
Psilocybin Eases Psychological Distress In People Who Experienced Childhood Trauma, Study Suggests – Marijuana Moment
A new study into the therapeutic effects of psilocybin suggests that use of the psychedelic drug can help ease psychological distress in people who had adverse experiences as children. Researchers...
Read More
The 3 Predictors of the Intensity of a Psychedelic Experience
Ê What variables, if any, can predict the intensity of a psychedelic mystical experience? Perhaps a better question to ask is: why would identifying
Read More
Why Do Shrooms Make You Yawn? And Why It’s Ok
Yawning is most commonly observed during the come-up phase when your digestive system is actively converting the ingested psilocybin into psilocin, th
Read More
Churches Using Mushrooms, Psilocybin for Religious Use – Mushrooms in Religion
ThereÕs a growing movement among religious leaders to use psychedelics like psilocybin to deepen their faith. The author attended a secret ceremony to find out whether it works.
Read More
Psychedelic drugs help veteran with PTSD, study shows
In a breakthrough that may transform how PTSD is treated in veterans, MDMA-assisted therapy appears to yield promising results.
Read More
Psychedelic drugs secreted from toads boosts cognitive functioning ¥ Earth.com
A combination of two psychedelic drugs demonstrated significant efficacy in treating a range of symptoms in combat veterans.
Read More
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low and...
Read More
Psilocybin Ð Summary of knowledge and new perspectives – ScienceDire ...
Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a reseaÉ
Read More
Psilocybe Cubensis and Other Types of Magic Mushrooms You Should Know ̵ ...
Magic mushrooms are so incredible and mysterious, from the beautiful experiences they occasion to the mystical compounds that they naturally produce. But
Read More
Psilocybin Treatment for Major Depression Effective for Up to a Year for Mo ...
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
Read More
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DM ...
N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and periphery, and brain concentrations of DMT in rats. INMT transcripts were identified in the cerebral cortex, pineal gland, and choroid plexus of both rats and humans via in situ hybridization. Notably, INMT mRNA was colocalized with AADC transcript in rat brain tissues, in contrast to rat peripheral tissues where there existed little overlapping expression of INMT with AADC transcripts. Additionally, extracellular concentrations of DMT in the cerebral cortex of normal behaving rats, with or without the pineal gland, were similar to those of canonical monoamine neurotransmitters including serotonin. A significant increase of DMT levels in the rat visual cortex was observed following induction of experimental cardiac arrest, a finding independent of an intact pineal gland. These results show for the first time that the rat brain is capable of synthesizing and releasing DMT at concentrations comparable to known monoamine neurotransmitters and raise the possibility that this phenomenon may occur similarly in human brains.
Read More
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-S ...
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the…
Read More
Psilocybin Treatment for Major Depression Effective for Up to a Year for Mo ...
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
Read More
Psilocybin Ð Summary of knowledge and new perspectives – ScienceDire ...
Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a reseaÉ
Read More
Psilocybe Cubensis and Other Types of Magic Mushrooms You Should Know ̵ ...
Magic mushrooms are so incredible and mysterious, from the beautiful experiences they occasion to the mystical compounds that they naturally produce. But
Read More
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DM ...
N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and periphery, and brain concentrations of DMT in rats. INMT transcripts were identified in the cerebral cortex, pineal gland, and choroid plexus of both rats and humans via in situ hybridization. Notably, INMT mRNA was colocalized with AADC transcript in rat brain tissues, in contrast to rat peripheral tissues where there existed little overlapping expression of INMT with AADC transcripts. Additionally, extracellular concentrations of DMT in the cerebral cortex of normal behaving rats, with or without the pineal gland, were similar to those of canonical monoamine neurotransmitters including serotonin. A significant increase of DMT levels in the rat visual cortex was observed following induction of experimental cardiac arrest, a finding independent of an intact pineal gland. These results show for the first time that the rat brain is capable of synthesizing and releasing DMT at concentrations comparable to known monoamine neurotransmitters and raise the possibility that this phenomenon may occur similarly in human brains.
Read More
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-S ...
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the…
Read More
Popular News
Changa: What is Changa? The Truth About Smokeable Ayahuasca – DoubleB ...
In many ways, exploring psychedelics involves opening your mind to the one thing that human beings fear most: death. And... Read More
Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? &# ...
This article by Bia Labate and Kevin Feeney explores problematic actions taken by Decriminalize Nature (DN), in regards to the... Read More
Placebo-controlled study suggests that the benefits of psilocybin microdosi ...
Anecdotal evidence suggests that microdosing with psilocybin mushrooms offers mental health benefits. But a recent experimental study suggests that these... Read More
Could psychedelics be used to help manage athletes’ mental health? | ...
David Lawrence, who works with the Toronto Blue Jays, says he's always on the lookout for emerging research in the... Read More
Oregon Psilocybin Service Centers Set High Prices, Thousands Have Already W ...
Three months of legal psilocybin service with EPIC Healing Eugene show that thousands of people are reaching out to participate. Read More
Microdoses of psychedelic drugs can ease anxiety, depression: UBC study | G ...
The study followed more than 8,000 people around the world, half of whom were microdosing with psychedelics like magic mushrooms. Read More